|MDACC Study No:||2013-0479(2005-0813CML) (clinicaltrials.gov NCT No: NCT01903733)|
|Title:||An Open-Label Bosutinib Treatment Extension Study for Subjects with Chronic Myeloid Leukemia (CML) Who Have Previously Participated in Bosutinib Studies B1871006 or B1871008|
|Principal Investigator:||Jorge Cortes|
|Study Description:||The goal of this clinical research study is to learn about the long-term side |
effects of Bosulif (bosutinib) after you discontinue therapy.